Actively Recruiting
Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients
Led by Thomas Jefferson University · Updated on 2025-06-24
110
Participants Needed
1
Research Sites
439 weeks
Total Duration
On this page
Sponsors
T
Thomas Jefferson University
Lead Sponsor
M
Merck Sharp & Dohme LLC
Collaborating Sponsor
AI-Summary
What this Trial Is About
Einstein Medical Center in Philadelphia serves a diverse group of the patient population. The majority of patients have a diverse cultural background, low literacy, and poor social-economic status. Medication adherence for chronic medical problems is in a range of 40-70%. Medication adherence among patients on oral anti-cancer therapy is not studied in detail. The main objective is to study medication adherence to oral anticancer agents in patients with low literacy and poor socio-economic status.
CONDITIONS
Official Title
Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients on oral chemotherapeutic agents
- Clinical diagnosis of stage IV breast cancer
- Clinical diagnosis of stage III and IV colorectal cancer not receiving concurrent radiation therapy
- Clinical diagnosis of stage IV non-small cell lung cancer
- Clinical diagnosis of stage IV renal cell carcinoma
- Clinical diagnosis of stage IV ovarian carcinoma
- Clinical diagnosis of multiple myeloma
- Clinical diagnosis of chronic myelogenous leukemia on TKI
- Clinical diagnosis of myelodysplastic syndrome on Lenalidomide
- Adjuvant treatment for gastrointestinal stromal tumor
- Clinical diagnosis of chronic lymphocytic leukemia
- Clinical diagnosis of metastatic prostate cancer
- Clinical diagnosis of hepatocellular carcinoma
- Clinical diagnosis of stage IV melanoma
- Clinical diagnosis of myelofibrosis or myeloproliferative neoplasms
- Age over 18 years
- ECOG Performance Status less than 3
You will not qualify if you...
- ECOG Performance Status of 3 or higher
- Concurrent chemo radiation
- Non-English speaker
- Clinical diagnosis of dementia or unable to give informed consent
- History of non-compliance with at least 2 missed clinic appointments
- Pregnant patients
- Nursing home patients
- Incarcerated individuals
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Albert Einstein Healthcare Network
Philadelphia, Pennsylvania, United States, 19141
Actively Recruiting
Research Team
C
Claudia M Dourado, MD
CONTACT
C
Claudia Dourado
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here